RGNT — REGENTIS BIOMATERIALS LTD.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1912966 ·
Israel
Last close
$3.79
Market Cap
$26.62M
52W High
$15.50
52W Low
$1.23
ADV30
11,071,728
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 7,618,000 | 7,378,000 | 2,874,000 |
| Jun 2025 | — | — | — | — | 475,000 | 189,000 | 44,807,000 |
| Dec 2024 | — | — | — | — | 482,000 | 229,000 | 41,586,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-55,794,000
Inventory
—
Receivables
$230,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -8,619,000 | -13,648,000 | 7,618,000 | 2,874,000 | — | -1,375,000 |
| Dec 2024 | 0 | 932,000 | 4,801,000 | 482,000 | 41,586,000 | — | -641,000 |
| Dec 2023 | 0 | -1,931,000 | -4,132,000 | 360,000 | 46,265,000 | — | -1,220,000 |
| Dec 2022 | 0 | -1,407,000 | -1,449,000 | 1,717,000 | 43,778,000 | — | -1,504,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $27.32M | $0.90 | — |
| PLRZ | Polyrizon Ltd. | $27.42M | $14.65 | — |
| PSTV | PLUS THERAPEUTICS, INC. | $27.54M | $4.00 | — |
| PLSM | Pulsenmore Ltd. | $25.10M | $3.86 | — |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $25.06M | $2.88 | — |
News headlines (Yahoo Finance, 1h cache)
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
2026-06-18 01:05 · Yahoo
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation
2026-06-16 18:00 · Yahoo
Why Did RGNT Stock Surge More Than 850% Today?
2026-06-15 18:06 · Yahoo
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC
2026-06-08 19:30 · Yahoo
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
2026-06-08 12:32 · Yahoo
Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones
2026-06-01 19:15 · Yahoo
Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant
2026-05-29 19:15 · Yahoo
Regentis Biomaterials (RGNT) Is 'One to Watch'
2026-05-28 19:30 · Yahoo
Regentis Biomaterials (RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair
2026-05-26 19:40 · Yahoo
Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon
2026-04-16 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.